Related Tags >> Bristol-Myers Squibb ipilimumab Roche biopharmaceutical company

Melanoma News

Most Popular Melanoma Story

GSK will cut 3 R&D units, add 4 as DPU review triggers shakeup

February 7, 2012 — 8:45am ET | By John Carroll

Following a three-year review of its new approach to R&D, GlaxoSmithKline ($GSK) today revealed that it has decided to ax three of its 38 tightly-focused research units and add four more in a Read more...

Melanoma Press Releases

BioAlliance Pharma Announces Two Key Steps with Its AMEP™ Biotherapy for Metastatic Melanoma
PV-10 Mechanism of Action Data to Be Presented at the Society of Surgical Oncology Annual Meeting March 21-24, 2012 in Orl
HistoRx Licenses Melanoma Assay from Yale University
Ohio State researchers discover hereditary predisposition of melanoma of the eye
Medical Oncologists Have Rapidly Adopted Yervoy and Zelboraf in All Lines of Therapy for the Treatment of Metastatic Melan

Latest Headlines

GSK will cut 3 R&D units, add 4 as DPU review triggers shakeup
February 7, 2012
Roche gets key nod for targeted skin cancer drug en route to EU approval
December 16, 2011
Roche wins early approval for blockbuster melanoma drug vemurafenib
August 17, 2011
Report: FDA approval for Roche's melanoma drug vemurafenib 'imminent'
August 9, 2011
Bristol-Myers grabs EU approval of key melanoma drug
July 14, 2011
Roche's vemurafenib plays a starring role at ASCO
June 6, 2011
BMS, Roche join forces and drugs on combo melanoma program
June 2, 2011
Roche, GSK melanoma drugs in ASCO's "hottest" spotlight
May 25, 2011
Roche cancer programs angle for a starring role at ASCO
May 18, 2011
FDA approves Bristol's Yervoy (ipilimumab) for melanoma
March 25, 2011
FDA nears deadline on closely-watched melanoma drug
March 24, 2011
Bristol's breakthrough melanoma drug delivers promising data in Ph3
March 22, 2011
GSK pushes two melanoma drugs into crowded Ph3 arena
January 24, 2011
Lilly dealt another blow as investigators suspend Ph3 melanoma trial
December 14, 2010
Plexxikon, Roche melanoma drug shows promise in trial
November 5, 2010
ZymoGenetics turns in stellar IIa data on melanoma program
September 29, 2010
Roche melanoma drug registers striking results
August 26, 2010
Benlysta, BMS melanoma drug win accelerated FDA review
August 19, 2010
First human trial on melanoma vax 'cure'
May 20, 2010
Synta halts "stunningly disappointing" melanoma trial
February 27, 2009

Paid Research Reports

More Research Reports >>

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events